Semax

• Week 1-2: Some report subtle focus gains; mild headache possible
• Week 2-4: Break weeks: see if focus slips without it
• Week 4-8: Round 2, then break; too wired? One morning dose
• Week 8-12: Round 3, then break; long-term effects unknown
• Side effects: Sometimes headache, poor sleep; 911: face or throat swelling, seizure

More on each stage

Week 1-2

Round 1 (on). Community users report focus within 15 to 30 minutes of a nasal dose; how fast an injection works has not been documented. Expect subtle effects: clearer focus, less mental fatigue, steadier motivation. A mild headache when you first start is reported. In rats, a brain-growth signal (BDNF) was raised 3 hours after a nasal dose.

Week 2-4

Your first 2-week break (weeks 3 and 4). Notice whether focus and stamina slip back without it. That is the best sign of whether it helped you. In stroke patients given two 10-day courses 20 days apart, blood BDNF stayed raised through the gap. That was in stroke patients, not healthy people.

Week 4-8

Round 2 in weeks 5 and 6, then a break in weeks 7 and 8. Community guides say steady focus is easier to judge after 2 to 4 weeks of use. If you felt wired or slept badly in round 1, stay at one morning dose.

Week 8-12

Round 3 in weeks 9 and 10, then a break in weeks 11 and 12. No study has followed healthy people on Semax this long, so long-term effects are unknown. If you noticed nothing across two rounds, more rounds are unlikely to help.

Side effects

Most often a mild headache, or trouble sleeping when taken late in the day (each reported by 1 to 10 in 100 users). Less often, feeling wired or anxious. Stop and get help right away for swelling of the face or throat, trouble breathing, a seizure, or severe agitation.

Based on what people report in the community sources below. Results vary, and many responses are anecdotal.

• Stroke recovery

  Human study

  Semax is approved in Russia for stroke. In 30 people with an acute stroke, adding Semax to standard care sped up recovery of movement compared with 80 similar patients. In a study of 110 people in stroke rehab, those given Semax had higher blood BDNF and better daily-living scores than those who were not.146

• Memory and attention

  Human study

  Russian developers reported that nasal Semax improved memory and attention in healthy men under demanding conditions, with each dose working for 20 to 24 hours.32

• Changes in brain activity

  Human study

  In 24 healthy adults, one nasal dose changed resting brain-network activity on an MRI scan within 20 minutes, compared with placebo.72

• Brain growth signal (BDNF)

  Animal/lab study

  In rats, Semax raised BDNF, a protein that helps brain cells form and strengthen connections, within 3 hours of a nasal dose. It also raised BDNF in the hippocampus, a memory center.89

• Stress and low mood

  Animal/lab study

  In rats under long-term unpredictable stress, daily Semax injections reversed the loss of interest in a sweet reward (a sign of depression-like mood) and restored BDNF in the hippocampus.13

• Focus without the jitters

  Community report

  Community users most often report clearer focus and mental clarity, plus better motivation, word-finding, and productivity. Some describe a subtle lift in mood.19

What it has been studied for

• Ischemic stroke, the kind caused by a blocked blood vessel (approved in Russia as 1% nasal drops; small Russian studies)146Human study
• Memory and thinking problems from poor brain blood flow, after head injury or surgery, and optic nerve damage (Russian label for 0.1% drops)12Human study
• Slowing the decline from long-term poor blood flow to the brain (187 patients, Russian study)5Human study
• Memory and attention in healthy men under demanding conditions (developers' report)32Human study
• Depression-like behavior from chronic stress13Animal/lab study
• Brain protection after stroke (rat gene study)14Animal/lab study
• Protecting heart muscle cells after a heart attack (rats)15Animal/lab study

Semax is a lab-made chain of 7 building blocks (amino acids). It copies a small piece of a stress hormone (ACTH), plus a 3-block tail that makes its effects last longer. It does none of that hormone's usual hormone jobs. In rats, a nasal dose reaches the brain within minutes and raises BDNF, a protein that helps brain cells grow and connect. In rats it also raised serotonin activity and made the dopamine boost from stimulants stronger (both are brain messengers). After strokes in rats, it turned down inflammation genes and turned up nerve-signalling genes.

Peak

Not established in humans for injection under the skin. In rats given nasal drops, Semax reached the brain within 2 minutes. The Russian label says nasal Semax crosses into the brain within 4 minutes. In rats, BDNF was raised 3 hours after a nasal dose; one review notes it was no longer raised at 24 hours.

Half-life

Not established in humans. Enzymes in the blood break Semax down quickly; no exact figure has been published in English. Its effects outlast it: the Russian label and its developers say one dose works for 20 to 24 hours.

Cleared

In lab tests it breaks into smaller pieces, mainly Pro-Gly-Pro and His-Phe-Pro-Gly-Pro. The Russian label says it leaves the body in urine. How long it takes to clear a dose completely is not established in humans.

Half-life is how long it takes the body to remove half of a dose.1101182

Once a day to start. The store plan allows a second dose. In the morning. If you add a second dose, take it by early afternoon. Late-day doses can keep you awake. Every day (7 days a week) during each 2-week on-cycle. Units are for a 30 mg vial mixed with 2 mL water (15 mg per mL).

• Lower end · conservative start dose

  About 0.5 mg subcutaneously per administration

  A sub-milligram subcutaneous dose community planners describe as a conservative start to gauge cognitive response and tolerance before stepping up.1922

• Most common · community standard; BDNF sweet spot

  1 mg subcutaneously, 2-3 mornings per week

  The standard community subcutaneous protocol — reconstituted from a research vial, injected in the morning, cycled 8 weeks on / 8 weeks off. Reported as the BDNF 'sweet spot' without overdriving stimulation.1921

• Higher end · acute-focus daily

  2 mg subcutaneously once daily

  An acute-focus daily subcutaneous protocol some run during demanding cognitive stretches — offset by overstimulation and sleep disruption if dosed late.1921

• Daily injection (not tested in trials)

  300-600 mcg under the skin once a day for 2 to 4 weeks. The store dose of 400 mcg fits this pattern.19

• Intermittent injection (not tested in trials)

  1 mg under the skin 2 to 3 mornings a week, 8 weeks on and 8 weeks off. With this vial's mix, 1 mg is about 6.7 units; the closest mark, 6.5 units, gives 975 mcg.21

• Nasal spray (not tested in trials)

  200-600 mcg once or twice a day, mornings preferred, for 10 to 14 days on and 7 to 14 days off.19

Research protocols

• Russian label: 0.1% nasal drops (memory, thinking, recovery)

  200-2,000 mcg per dose, 500-5,000 mcg a day, daily for 3 to 5 days, extendable to 14 days. One drop holds 50 mcg. The store dose of 400 mcg fits the per-dose range. The store gives it by injection, not nasally, and nasal and injected doses are not equal.1

• Russian label: 1% nasal drops (acute stroke, in hospital)

  6,000-12,000 mcg a day for moderate strokes and 12,000-20,000 mcg a day for severe strokes, split into 3 to 5 doses, for 10 days.1

• Stroke rehab study (110 patients)

  6,000 mcg a day for 10 days, a 20-day break, then another 10 days.6

• Healthy adults, brain-scan study (24 people)

  One nasal dose of 1% solution, 1.2 mg in total, against placebo.72

• Rats (BDNF)

  50 or 250 mcg per kg of body weight, once, as nasal drops.8

Semax is approved in Russia (for stroke recovery and cognitive disorders) but not by the FDA or EMA. Published human data for subcutaneous use is sparse. Semax was on the FDA 503A Category 2 list (immunogenicity concern) until the nomination was withdrawn in April 2026 — removal is procedural, not a safety clearance. Overstimulation and sleep disruption are reported, especially with late-day dosing.

Dosing guidance built from the cited research and community reports. It is not a prescription.

1. 1
2. 2
3. 3
4. 4

On: 2 weeks Break: 2 weeks

A full course at the store pace takes 1 vial. A mixed vial keeps for up to 90 days.

Why the break helps

No study has tested breaks for Semax used this way. The Russian label uses short courses: daily for 3 to 5 days, up to 14 days. A stroke study gave two 10-day courses with a 20-day gap. Community users run 10 to 14 days on and 7 to 14 days off. The break gives you a clean comparison, so you can tell whether Semax is helping your focus. It also limits nonstop use of a compound with no long-term safety data in healthy people.

Common

• Mild headache, mostly when you first start or at higher doses (reported by 1 to 10 in 100 users)

  What to do Drink water and rest; a regular pain reliever usually helps. If it keeps coming back, drop to 300 mcg (2 units) or stop.

• Trouble falling asleep, mostly when taken later in the day

  What to do Take it in the morning, and take any second dose by early afternoon. If sleep still suffers, stay at one morning dose.

• Feeling wired, restless, anxious, or irritable. One community guide links overstimulation to doses above 600-900 mcg a day. Other guides link a 'too activated' feeling to stacking with caffeine or other stimulants. Anxiety or agitation is reported by fewer than 1 in 100 users, mostly at higher doses.

  What to do Lower the dose or drop to once a day, and cut back on caffeine on dosing days. If it does not settle, stop.

• Higher blood sugar in people with diabetes (about 7 in 100 diabetic patients in Russian use)

  What to do If you have diabetes, check your blood sugar more often while on Semax and tell your doctor.

• Redness, itching, or a small lump where you inject

  What to do Rotate sites each time. It should fade within a day or two.

Stop and get help

• Allergic reaction: swelling of the face, lips, or throat, trouble breathing, wheezing, or a widespread rash

  What to do Stop Semax and call 911 (or your local emergency number) right away. Do not take it again. The FDA flagged Semax for a risk of immune reactions by some routes, because the peptide can clump together and carry impurities. Injection under the skin has not been tested for this in people.

• A seizure

  What to do Call 911. Stop Semax and do not take it again. A history of seizures is on the Russian label's list of reasons not to use it.

• Severe anxiety, panic, agitation, or losing touch with reality (seeing or hearing things, paranoid thoughts)

  What to do Stop Semax and get medical help the same day. The Russian label warns against Semax in acute psychosis and in conditions that come with anxiety.

• Infection where you inject: redness that spreads, heat, pus, red streaks, or fever

  What to do Stop injecting and see a doctor the same day.

Do not use if

• You are pregnant, trying to get pregnant, or breastfeeding (pregnancy and breastfeeding are on the Russian label's list of reasons not to use it).
• You have acute psychosis (losing touch with reality) right now, or a disorder that comes with anxiety (both on the Russian label's list).
• You have ever had a seizure (on the Russian label's list).
• You have had an allergic reaction to Semax.
• You are under 18. This guide is written for adults only. The Russian label rules out its 0.1% nasal drops under age 5, and allows them from age 5 only to treat minimal brain dysfunction, including ADHD.

Sources20

Storage

Keep it

Keep the mixed vial in the fridge (2-8 °C / 36-46 °F), away from heat and light, and do not leave it out at room temperature. Do not freeze it: heat and freezing make the peptide more likely to clump.

How long

Use within 90 days of mixing. A mixed vial kept in the fridge holds its strength for 60-90 days, then slowly starts to lose potency. Wipe the rubber top with an alcohol swab before every draw.

Drawing your dose

Syringe: a 0.3 mL (30-unit) U-100 insulin syringe with half-unit marks, so small doses are easy to read.

1. With this mix, every 1 unit line on a U-100 insulin syringe holds 150 mcg. Draw to the 2.5-unit mark for 375 mcg, the closest mark to 400 mcg. Draw to 2 units for 300 mcg, or 4 units for 600 mcg.
2. Online guides often assume 3 mL of water in a 30 mg vial. Their unit numbers will not match this mix. Always go by the units on this page.
3. Hold the syringe at eye level, flick out air bubbles, and push the plunger back to the exact line.
4. Pinch a fold of skin, insert the needle at 45 to 90 degrees, push slowly, and wait a few seconds before pulling out.
5. Do not mix Selank or anything else into the same syringe. Use a new sterile syringe every time and never share one.
6. Missed a dose? If it is already late afternoon, skip it and take the next one the next morning. Do not double up.

• Selank

  One community guide calls Semax with Selank the most popular nootropic peptide stack: Semax for drive and focus, Selank for calm, with the aim of calm alertness without overstimulation. In a Russian study of 62 people with generalized anxiety disorder or nervous exhaustion (neurasthenia), the 30 given Selank had anxiety relief similar to the 32 given medazepam, a benzodiazepine (a standard anti-anxiety drug). No clinical trial has tested Semax and Selank together.19222118

Interactions

• Stimulant ADHD medicines (amphetamine such as Adderall, methylphenidate such as Ritalin)

  In rats, Semax given before amphetamine sharply boosted its dopamine release and activity. This has not been studied in people.

  What to do Talk to your prescriber before combining. Watch for a racing heart, jitteriness, anxiety, or poor sleep.

• Caffeine, pre-workout drinks, and other stimulants

  Community guides report overstimulation, a 'too activated' feeling, when Semax is stacked with caffeine or other stimulants.

  What to do Cut back on caffeine on dosing days, especially at first.

• Insulin and other diabetes medicines

  Blood sugar rose in about 7 in 100 people with diabetes during Russian use.

  What to do Check your blood sugar more often and tell your doctor you are taking Semax.

• Antidepressants that act on serotonin (SSRIs, SNRIs, MAOIs)

  Not studied. Semax raised serotonin turnover in rat brains, so an added effect is possible in theory.

  What to do Ask your prescriber before combining, and do not stop an antidepressant on your own.

Videos

• Why SEMAX Is the Peptide Everyone's Talking About for Focus & Learning
• Benefits & Risks of Peptide Therapeutics (Huberman Lab)Andrew Huberman

Sources

1. 1Semax 0.1% and 1% nasal drops, Russian prescribing information (RLS drug encyclopedia)Drug label
2. 2Alzheimer's Drug Discovery Foundation, Cognitive Vitality report: SemaxReview
3. 3Ashmarin et al., Zh Vyssh Nerv Deiat 1997: 15 years of Semax research (review)Review
4. 4Gusev et al., Zh Nevrol Psikhiatr 1997: Semax in acute ischemic strokeStudy
5. 5Gusev et al., Zh Nevrol Psikhiatr 2005: Semax in cerebrovascular insufficiencyStudy
6. 6Gusev et al., Zh Nevrol Psikhiatr 2018: Semax, BDNF, and stroke rehabilitationStudy
7. 7Lebedeva et al., Bull Exp Biol Med 2018: Semax and the brain's default mode network (fMRI)Study
8. 8Dolotov et al., J Neurochem 2006: Semax binds and raises BDNF in rat basal forebrainStudy
9. 9Dolotov et al., Dokl Biol Sci 2003: Semax stimulates BDNF expression in rat brainStudy
10. 10Shevchenko et al., Bioorg Khim 2006: how fast Semax reaches rat brain and bloodStudy
11. 11Zolotarev et al., Bioorg Khim 2006: breakdown of Semax and SelankStudy
12. 12Eremin et al., Neurochem Res 2005: Semax, dopamine, and serotonin in rodentsStudy
13. 13Inozemtseva et al., Eur J Pharmacol 2024: Semax in a rat chronic-stress modelStudy
14. 14Filippenkov et al., Genes 2020: Semax and brain genes after stroke in ratsStudy
15. 15Golubeva et al., Ross Fiziol Zh 2006: Semax and the rat heart after heart attackStudy
16. 16Cherkasova et al., Bull Exp Biol Med 2001: Semax and blood clotting in ratsStudy
17. 17Umarova et al., Bull Exp Biol Med 2003: Semax and mast cells under stressStudy
18. 18Zozulia et al., Zh Nevrol Psikhiatr 2008: Selank in generalized anxiety disorderStudy
19. 19Peptide Protocol Wiki: Semax community protocols (130 reports)Community
20. 20Peptide Protocol Wiki: Semax side effects and interactionsCommunity
21. 21The Peptide Catalog: Semax dosing guide (SubQ protocol, mixing, storage)Community
22. 22Peptide Dosing Protocols: Semax research-context guideCommunity

Where people discuss it

• r/Nootropics (subreddit)
• Peptide Protocol Wiki — Semax community (130 reports)
• The Peptide Catalog — Semax SubQ protocol

Some peptides, like semaglutide (Ozempic and Wegovy), are FDA-approved medicines. Most of the peptides people research are not. That label sounds like the FDA tested something and turned it down. Usually it means something else: nobody has paid for the studies the FDA needs to see. Here is why.

The FDA doesn’t test drugs. Companies do.

The FDA does not run its own drug tests. A company that wants to sell a new medicine has to test it first, and pay for it. It studies the drug in animals, then in people: first 20 to 100 volunteers, then a few hundred, then up to 3,000. Then it sends all the results to the FDA. FDA scientists review them and decide whether the benefits outweigh the risks.

So approval always starts with a company asking for it. If no company applies, the FDA has nothing to review, however promising the research looks.

Those studies cost about a billion dollars

A study in the medical journal JAMA estimated that bringing one new drug to market costs a typical company about $1.1 billion. That figure includes the money spent on drug ideas that failed along the way, because many drugs that start human testing never make it.

A patent is how a company earns that money back

A patent is a right the government gives an inventor. For up to 20 years from the day the inventor applies, nobody else may make or sell the invention without permission.

For a drug company, that right is what makes the billion-dollar bet worth it. While the patent lasts, the company is the only seller, so it can charge enough to pay back the studies and the failures. When the patent runs out, other companies can sell cheap copies, called generics, and the price drops.

The FDA adds a shorter shield of its own. For 5 years after a brand-new drug is approved, no copycat version can apply for approval. That helps, but it is much shorter than a patent can last.

Why most peptides can’t be patented

To get a patent, an invention has to be new, and it has to be something people made, not something found in nature. Most popular peptides fail one test or both.

They come from nature. Many are copies or small pieces of molecules your body already makes. KPV is a 3-building-block piece of the hormone that tans your skin. BPC-157 is copied from a protein in stomach juice. In 2013 the US Supreme Court ruled that something that exists in nature, like a human gene, cannot be patented just because someone found it and pulled it out.

They aren’t new anymore. Many were first described in research papers decades ago. Scientists were already testing KPV in the 1980s. Once something has been published, it no longer counts as new, so nobody can patent it now, and any patents from back then have long since run out.

Without a patent, a company that paid for the studies would soon face rivals selling the same peptide without having paid for any research. Few companies will spend a billion dollars on a product anyone can copy. So nobody goes first, and the large human studies never happen.

The workaround: change the molecule

Drug companies do make peptide medicines, but they change the peptide first. A changed molecule is a new invention, so it can be patented. Semaglutide is a lab-made version of GLP-1, a gut hormone your body releases after meals, changed so one shot lasts a week. Tesamorelin (Egrifta) is the body’s own growth-hormone signal with a small fatty chain added. Both went through the full studies, and both are FDA-approved.

The natural versions, and the many peptides nobody has changed and patented, stay where they are: studied in labs and animals, used by the biohacking community, and never put through large human trials.

What this means for you

When a peptide is “not FDA-approved,” it usually means no company has paid for the large human studies. It does not mean the FDA tested it and found it harmful.

It also does not mean it is proven safe or proven to work. Without those studies, nobody knows the best dose for sure, or what rare or long-term side effects it may have. And the FDA does not check research peptides for purity or strength the way it checks approved medicines. That is why this page labels every finding by the kind of study behind it, and lists who should not use it.

Sources for this section

1. 1FDA: How drugs are developed and approved (the FDA does not test drugs; companies submit the evidence)
2. 2FDA: The drug development process, step 3: clinical research (study sizes for each phase)
3. 3Wouters, McKee & Luyten, JAMA 2020, corrected 2022: median cost to bring a new drug to market, $1.14 billion
4. 4US patent law, 35 U.S.C. § 154: a patent lasts 20 years from the filing date
5. 5FDA: Frequently asked questions on patents and exclusivity (5-year new chemical entity exclusivity)
6. 6US Supreme Court, Association for Molecular Pathology v. Myriad Genetics (2013): naturally occurring genes cannot be patented